Salem Fitsum
Psychiatric/Mental Health · Las Vegas, NVNPI 1861177131
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 329 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,465, more than ten times the $395 reported in 2023. Among psychiatric/mental health clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 329 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Vanda Pharmaceuticals Inc.$779
- Neurocrine Biosciences, Inc.$740
- plus $2K from 13 others
What the payments were for
- Food & beverage$8,524100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 47 | $1,409 |
| AbbVie | 49 | $1,276 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 45 | $1,219 |
| Otsuka America Pharmaceutical, Inc. | 42 | $1,159 |
| Vanda Pharmaceuticals Inc. | 19 | $779 |
| Neurocrine Biosciences, Inc. | 27 | $740 |
| E.r. Squibb & Sons, L.L.C. | 21 | $469 |
| Johnson & Johnson | 17 | $377 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $189 |
| Supernus Pharmaceuticals, Inc. | 14 | $173 |
| Braeburn Inc. | 6 | $144 |
| Indivior Inc. | 5 | $119 |
| Axsome Therapeutics, Inc. | 6 | $113 |
| Lundbeck LLC | 6 | $97 |
| Teva Pharmaceuticals USA, Inc. | 5 | $90 |
| Sage Therapeutics, LLC | 5 | $81 |
| Corium, LLC | 4 | $59 |
| Almatica Pharma LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$934
- VRAYLAR$522
- ARISTADA$477
- CAPLYTA$278
- Fanapt$250
- ABILIFY MAINTENA$242
- ABILIFY ASIMTUFII$242
- INGREZZA$175
- ARISTADA INITIO$119
How this compares
$8,536 in reported general payments places this provider in the 95th percentile of 362 psychiatric/mental health providers in Nevada.
Other psychiatric/mental health in Las Vegas
- Michelle GiddingsLas Vegas$131K
- Patrick ApiladoLas Vegas$19K
- Joshua HamiltonLas Vegas$17K
- Sydney EganLas Vegas$14K
- Ma Victoria EscardaLas Vegas$12K
- Carminia SalvacionLas Vegas$12K
- Valentina AkohLas Vegas$12K
- Angela WilsonLas Vegas$11K
- Michael MathisenLas Vegas$10K
- Edina BorosLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.